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Abstract
Objective: To evaluate 3D spectral domain optical coherence tomography (SDOCT) volume scans as a tool for quantification
of optic nerve head (ONH) volume as a potential marker for treatment effectiveness and disease progression in idiopathic
intracranial hypertension (IIH).
Design and Patients: Cross-sectional pilot trial comparing 19 IIH patients and controls matched for gender, age and body
mass index. Each participant underwent SDOCT. A custom segmentation algorithm was developed to quantify ONH volume
(ONHV) and height (ONHH) in 3D volume scans.
Results:Whereas peripapillary retinal nerve fiber layer thickness did not show differences between controls and IIH patients,
the newly developed 3D parameters ONHV and ONHH were able to discriminate between controls, treated and untreated
patients. Both ONHV and ONHH measures were related to levels of intracranial pressure (ICP).
Conclusion: Our findings suggest 3D ONH measures as assessed by SDOCT as potential diagnostic and progression markers
in IIH and other disorders with increased ICP. SDOCT may promise a fast and easy diagnostic alternative to repeated lumbar
punctures and could therefore ease monitoring of treatment or disease progression.
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Introduction
Idiopathic intracranial hypertension (IIH), also known as
pseudotumor cerebri (PTC), is a clinical syndrome of unknown
etiology characterized by increased intracranial pressure (ICP)
which typically affects young, obese women of childbearing age
[1–5]. Clinical symptoms include headache, visual disturbances,
pulsating tinnitus, photopia, eye pain, diplopia and nausea.
Papilledema with subsequent visual field loss is the most feared
clinical consequence, which mainly determines the therapy and
outcome of the syndrome [6–9]. However, although detection of
papilledema by an experienced ophthalmologist is a powerful tool
in primary diagnosis, it remains a limited method in producing
quantitative data to evaluate longitudinal optic disc changes in
patients with IIH [10,11].
Optical coherence tomography (OCT) is a non-invasive
imaging method, which creates in vivo cross-sectional patterns of
the retina [12]. In recent years, OCT has become a valuable tool
for assessing retinal axonal damage in several neurological diseases
such as optic neuritis, multiple sclerosis, neuromyelitis optica,
spinocerebellar ataxia, and Parkinson’s disease [13–20]. More-
over, OCT is associated both with morphologic and metabolic
changes in brain, thus providing an easy accessible window into
the brain in neurologic diseases [21–23].
Few studies investigated OCT in IIH using the retinal nerve
fiber layer thickness (RNFLT) in a peripapillary ring scan as
outcome parameter. Patients with newly diagnosed IIH presented
RNFL thickening compared to healthy controls, which decreased
after three months under IIH treatment, thus proposing RNFLT
as a potential longitudinal measure [24–26]. Subsequently it was
shown, that peripapillary RNFLT swelling due to increased ICP
correlates well with optic disc elevation or papilledema in
funduscopy [27]. However, all these studies used 2D time domain
OCT that does not allow direct 3D measurement of the optic
nerve head (ONH). Consequently, the peripapillary RNFLT
measurement is only a rough estimate of ONH changes as it is
located at the marginal zone of the pathologic process.
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Next generation 3D spectral-domain OCT (SDOCT) poten-
tially allows direct ONH quantification and has therefore been
proposed for evaluation of papilledema in IIH [28]. However,
ONH changes in patients with IIH (i.e. swelling) impede the use of
existing algorithms focusing on other diseases [29]. For this reason
we developed a novel custom segmentation algorithm using an
extension of the retinal pigment epithelium through the ONH as
reference line, which enabled us to automatically assess ONH
volume and shape in IIH patients that should also be applicable in
other diseases with elevated ICP and optic disc swelling.
Next, in a prospective cross-sectional pilot study we aimed to
quantify ONH differences by SDOCT between IIH patients and
matched controls. Lastly, we investigated a possible association
between SDOCT measures and clinical data which would be
relevant for the question whether ONH quantification may serve as
a tool for monitoring disease progression and therapeutic effects in
IIH.
Methods
Patients and Participants
The study included patients with a minimum age of 18 years
and a definite diagnosis of IIH according to the modified Dandy
criteria [30]. Patients were consecutively recruited from the
neurology outpatient clinic at the Charite´- Universita¨tsmedizin
Berlin between June 2010 and July 2011. Exclusion criteria were
systemic conditions or medication affecting ICP other than IIH
related medication, pregnancy or postpartum period, surgical
interventions affecting cerebro-spinal fluid circulation (e.g. shunt-
ing procedures or fenestration of the optic nerve sheath) and an
ophthalmological disease which could influence OCT imaging (i.e.
glaucoma).
All patients received a complete neurological examination
supervised by a board certified neurologist. The following data
were compiled: disease duration, current body mass index (BMI),
most recent lumbar puncture opening pressure (latest ICP),
current medical treatment and current IIH symptoms (i.e.
headache, visual obscurations, tinnitus, dizziness, nausea). For
measurement of ICP patients were lying on their right side in a
fetal position. After the subarachnoid space was punctured,
cerebrospinal fluid opening pressure was determined by the means
of a column manometer. A cohort of age, gender and BMI
matched controls was recruited among employees and obese
patients from the psychosomatic medicine department of the
Charite´- Universita¨tsmedizin Berlin, which were treated only for
adiposity. Symptoms of increased ICP as well as a diagnosis of IIH
were ruled out clinically in the control group by board certified
neurologists. The same exclusion criteria and examinations of the
patient group applied to the control group (CG). The study was
approved by the local ethics committee of the Charite´- Uni-
versita¨tsmedizin Berlin and was conducted in accordance to the
Declaration of Helsinki in its currently applicable version, the
guidelines of the International Conference on Harmonisation of
Good Clinical Practice (ICH-GCP) and the applicable German
laws. All participants gave informed written consent.
Optical Coherence Tomography
RNFLT, total macular volume (TMV) and 3D ONH scans
were obtained using a spectral-domain OCT (Heidelberg Spec-
tralis SDOCT, Heidelberg Engineering, Germany, Spectralis
software version 5.3.3.0, Eye Explorer software 1.6.4.0) for each
eye of the patients and matched controls. RNFLT was measured
using a 3.4 mm circular scan around the ONH with the device’s
standard protocol and segmentation algorithm with activated eye
tracker (TrueTrackH) and the maximum number of averaging
frames in ART–MEAN mode was tried to achieve. TMV was
measured by a custom protocol which generated 61 slices (B-scans)
focusing the fovea centralis with a scanning angle of 30u625u and
a resolution of 768 A-scans per B-scan. TMV was calculated by
estimating the distance between the inner limiting membrane and
the Bruch-membrane in a cylinder with 6 mm in diameter using
the device software’s segmentation algorithm. The 3D ONH scan
was performed using a custom protocol with 145 slices (B-scans),
focusing the optic nerve head with a scanning angle of 15u615u
and a resolution of 384 A-scans per B-scan.
All scans were acquired by one of three experienced operators
and were reviewed for sufficient signal strength, correct centering
and segmentation by an independent operator not involved in the
study. All operators were blinded towards patient and control
groups; however, due to the nature of papilledema patients could
be easily identified in most cases by ONH images alone.
3D Optic Nerve Head Analysis
For the automatic assessment of ONH changes we developed a
custom and fully automatic algorithm that measures the volume
(ONHV) and maximum height (ONHH) of the disc edema. A
detailed description of the algorithm including reliability and
validation analyses is published elsewhere [31]. In brief, ONH
OCT scans tend to have regions of strong varying intensity values
caused by the edema. Additionally, scans are characterized by an
increased intrinsic speckle noise making a reliable differentiation of
intra retinal layers challenging to impossible. This algorithm
identifies and uses two reference boundaries on each B-scan, the
inner limiting membrane (ILM) and a hypothetical extension of
the peripapillary retinal pigment epithelium (RPE) through the
ONH. The edema is then defined as the area enclosed by these
two layers. The ILM is provided in sufficient quality by the
device’s segmentation software. In order to compute the volume
and maximal height of the edema the algorithm focuses on
segmenting the RPE to create a base area for further calculation of
both parameters. First an initial region that contains this layer is
estimated. Starting from this region, unnecessary pixels are
discarded. The RPE curve, describing the layer, is obtained by a
fully automatic least square spline fitting of 2nd or 3rd order
depending on the number of detected RPE segments. Further-
more, to account for the natural retinal curvature seen in SDOCT
images, we performed an image flattening on each slice using
again the RPE, followed by the final volume and height
computation. For the volume measurement a threshold of 20
pixels was applied from the reference height computed at the right
side and left side of each flattened B-scan. The area of the edema
found on each B-scan multiplied by the special spacing was
summed up to obtain the final volume. This threshold was selected
to include most of the ONH and to provide a satisfying volume of
the swelling in IIH as well as healthy controls. An overview of the
segmentation algorithm is shown in figure 1.
For algorithm development and application, 3D images were
exported from the SDOCT device and imported into Matlab
using a custom import filter based on documentation provided by
the device manufacturer. Development was performed using
Matlab R2011A with additional library Spline (Mathworks,
Ismaning, Germany).
Statistical Analysis
Differences between the two study groups were analyzed by
independent samples Mann-Whitney U test for age and BMI. For
evaluation of the relationship between RNFLT, TMV, ONH
parameters and clinical data, we performed generalized estimation
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equation (GEE) analyses with working correlation matrix structure
‘‘exchangeable’’ accounting for inter-eye/intra-patient dependen-
cies. Clinical parameters (diagnosis and treatment) were used as
independent and RNFLT, TMV or ONH parameters as
dependent variables. Correlation of RNFLT with ONHH or
ONHV was analyzed using Spearman’s Rho.
For identifying a possible relationship of ICP with ONHH or
ONHV we included only patients with an interval between ICP
and OCT measurements of less than 24 months (n = 11) and
additionally weighted data in GEE models with ICP as the
independent variable and either ONHH or ONHV as the
dependent variable by factor v =100/(measurement distance in
months+1). Hereby, OCT scans closer to the ICP measurements
are more strongly weighted in the subsequent analysis, whereas
scans with a longer interval are weighted less.
Reliability of ONHH and ONHV was determined using intra-
class correlation coefficient on repeated measurements using the
two-way mixed effects model where subject effects are random and
measures effects are fixed.
RNFLT percentiles for comparison with normal values are
given from the OCT device’s internal normative database. All
statistical analyses were performed with SPSS 19 (IBM SPSS
Statistics Version 19, Release 19.0.0.1, IBM, Armonk, NY, USA).
Statistical significance was established at p,0.05 in all analyses.
All tests should be understood as exploratory data analysis, in that
no previous power calculation and adjustments for multiple testing
were performed.
Results
Cohort description
This study enrolled 37 eyes from 19 IIH patients and 38 eyes
from 19 matched controls. One IIH eye had to be excluded due to
newly diagnosed epiretinal membranes. Demographics of patients
and controls are displayed in table 1. Patients and controls did not
differ regarding gender, age and BMI. Headache (84%) was the
most common symptom in IIH patients. Furthermore, all patients
suffered from at least one of the following visual symptoms during
the course of their disease: photopsia (79%), photophobia (58%),
blurred vision (42%) and visual acuity loss (26%). They also
described dizziness (58%), tinnitus (37%) and nausea (37%).
Thirteen patients were treated pharmacologically with either
acetazolamide (n = 11), topiramate (n = 1) or furosemide (n = 1) at
the time of OCT measurement.
RNFLT and TMV differences
We found no significant differences in average RNFLT and
TMV between IIH patients and CG (table 2). Although overall
group differences were not significant, seven eyes from four IIH
patients showed abnormally high RNFLT values above the 95th
percentile.
Reliability of ONH measurements and quantification
To determine the reliability of ONHV and ONHH, each eye
was measured three times in a row in 3 patients (6 eyes). Each
measurement was then post-processed in a fully automated fashion
using the presented algorithm. ICC for ONHV was 0.999 (p
,0.001) and ICC for ONHH was 0.983 (p ,0.001).
ONH volume and height differences
ONHV in patients was increased compared to controls (p
,0.001, table 2 and figure 2C). Furthermore, 18 eyes from 11 IIH
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Figure 1. Overview of the custom segmentation process for assessing ONH volume and height in IIH patients. 0) First OCT B scans are
cleaned from noise and smoothed, 1) then the area in which the RPE is expected is narrowed by removing bright upper layers of the scan, resulting in
the brightest spots belonging most likely to the RPE. 2) From the A scan at the first quarter and the A scan at the last quarter of the B scan, the
possible RPE area is further reduced by detecting the brightest spots of the image (red lines). 3) On the proposed RPE candidates a least square spline
approximation is applied (red line), resulting in a hypothetical RPE through the ONH. The ILM is provided from the device’s segmentation software
(blue line). 4) The scans are flattened using the RPE as reference. 5) Finally volume and height are calculated in the newly defined area.
doi:10.1371/journal.pone.0036965.g001
Table 1. Demographic overview of IIH patients and controls.
Parameter Patients Controls
N 19 19
Age (years) Mean 6 SD 38.0613.8 37.6612.9
Min–Max 20–63 20–61
Gender (female/male) N/N 17 / 2 17 / 2
BMI (kg/m2) Mean 6 SD 33.667.4 33.867.3
Min–Max 24.1–54.6 24.8–48.1
Disease duration
(months)
Mean 6 SD 40637 -
Min–Max 0–115 -
Latest ICP (cmH2O) Mean 6 SD 28.666.3 -
Min–Max 18.0–40.0 -
Time since last ICP
(months)
Mean 6 SD 20620 -
Min–Max 0–57 -
Abbreviations: IIH = idiopathic intracranial hypertension; ICP = intracranial
pressure; SD = standard deviation; Min = minimum value; Max = maximum
value.
doi:10.1371/journal.pone.0036965.t001
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patients showed an ONHV above the 95th percentile of the CG
(ONHV =2.09 mm3). ONHH did not differ between groups
(table 2). Two sample 3D ONH scans from a control subject and
an IIH patient are given in figure 2A and B. A receiver operating
characteristic analysis (ROC) between IIH patients and controls
presented a much higher area under the curve for ONHV (AUC
=0.835) than for RNFLT (AUC =0.464).
We further divided the patient group into treated and untreated
patients. Untreated patients (n = 6) showed a higher ONHV than
treated (n = 13) patients (GEE, p,0.001, table 3 and figure 2D).
Both medically treated and untreated patients had an increased
ONHV compared to controls which did not hold true for ONHH.
Additionally all but one eye from untreated patients showed an
ONHV above the 95th percentile of the CG. RNFLT analysis of
the subgroups displayed also an increase for untreated patients
(GEE, p= 0.03, table 3).
In a Spearman’s Rho analysis in IIH patients only, RNFLT
correlated both with ONHV (r = 0.501, p,0.001) and ONHH
(r = 0.482, p = 0.003).
Association of ICP with ONH volume and height
Lastly, we assessed the association of ONH measures and ICP.
Since the pilot trial design prohibited a direct measurement of ICP
next to OCT, we deployed the latest measured lumbar puncture
opening pressure, weighting it for the distance of measurement as
described in methods and including only patients with ICP
measurements closer to 24 months from OCT (n= 11).
Using this approach, GEE with ICP as the independent variable
weighted for distance of measurement and ONHV or ONHH as
the dependent variable were weakly significant for ONHV (B
= 0.020, SE = 0.007, p = 0.004) and interestingly significant for
ONHH with a negative association (B = 20.003, SE =0.0005,
p,0.001), meaning that IIH patients with a high ICP showed a
more depressed ONHH.
Discussion
In this pilot study we examined IIH patients and matched
controls using 3D SDOCT with a novel segmentation algorithm to
assess optic nerve head changes. Our main findings are: (a) ONH
volume was increased in IIH vs. CG and (b) in untreated versus
treated patients. (c) In contrast, neither RNFLT nor TMV differed
between IIH patients and controls, although a few patients showed
very high RNFLT values. (d) ONHV was weakly associated with
ICP, while ONHH showed an inverse association. Finally, (e) a
substantially higher proportion of IIH patients exhibited ONHV
values above the 95th percentile of controls (18 eyes of 11 patients,
57.9%, including all 6 untreated patients) as compared to RNFLT
(7 eyes of 4 patients, 21.0%) which indicates a higher susceptibility
of 3D ONH changes to alterations in ICP than RNFLT. ONH
volume showed a significant increase even in those IIH patients in
whom RNFLT remained normal. Thus, automated analysis of
ONH shape may present a first step towards detecting even
marginal changes in the composition of optic disc swelling. The
necessity of quantitative evaluation of the optic disc was recently
emphasized by another clinical study using transorbital sonogra-
phy to follow IIH patients around lumbar puncture to create a
more valuable tool for disease monitoring [32]. This study
investigated especially the 2D sonographic parameters optic nerve
sheath diameter (OSND), optic nerve diameter (OND) and optic
disc elevation. OSND was significantly increased in IIH patients
before lumbar puncture and decreased hereafter, while OND
showed no differences to controls. The penetration depth of OCT
disallows an evaluation of the optic disc sheath. On the other hand
SDOCT could detect morphological changes of the ONH and its
boundaries in more detail, because of the much higher resolution
than transorbital sonography (OCT optic resolution: 7 mm axial
and 14 mm lateral; sonographic resolution in millimeter range).
Thus, in the future both methods with their respective advantages
and limitations may complement each other in improving
assessment of the optic nerve head and sheath in IIH and other
conditions associated with increased ICP.
Our findings disclose several possibilities for using quantified
ONHV in practice. OCT could aid in new diagnosis of IIH,
providing an easy tool to quantify ONH swelling in patients with
unclear symptoms. Even if high inter-individual differences in
ONH shape limit usage in cross-sectional applications, assessing
changes in ONH might prove highly useful in longitudinal settings:
Automated 3D ONH assessment could be potentially used for
monitoring treatment effectiveness or for quantifying disease
progression. This aspect is supported by the higher ONHV in
pharmacologically untreated patients.
Of interest in this regard is the inverse association of ONH
maximal height and ICP: IIH patients with higher ICP show less
pronounced ONH height than patients with lower ICP. These
results suggest, that an ONH swelling process occurs more in a
plane base than in height, proposing ONHV as the more
meaningful parameter of ONH quantification. In addition a wall
at the rim of the optic disc is a non-pathological finding also in
healthy controls, which could influence the investigative power of
ONHH, because the rim is also detected by the algorithm
assessing ONHH. One could also speculate that this inverse
association is the result from damage to the RNFL occurring
during high-pressure phases. The assumption of RNFL damage as
a consequence of high ICP and papilledema is supported by the
fact that some of our patients showed reduced RNFL. However,
due to the sometimes long interval between ICP and OCT
measurements this result should be interpreted with caution.
In our study we could not approve the previously published
results of RNFLT differences between IIH patients and matched
controls in time domain OCT [24]. This might be explained in
part by differences in study design: First, we did not involve
patients with a newly confirmed IIH. The much longer disease
Table 2. Comparison of optical coherence tomography
measurements between IIH patients and controls.
Patients Controls GEE
Mean ±
SD
Min–
Max
Mean ±
SD
Min–
Max
RNFLT
(mm)
99.1618.1 58.4–155.5 99.268.0 79.9–111.9 P = 0.942
TMV
(mm3)
8.4860.40 7.72–9.01 8.6760.38 7.87–9.28 P = 0.141
ONHV
(mm3)
2.3061.25 0.41–5.97 1.0860.49 0.28–2.17 p,0.001
B= 1.2; SE
= 0.3
ONHH
(mm)
0.4260.07 0.3420.64 0.4060.03 0.3420.46 P = 0.099
Abbreviations: RNFLT = retinal nerve fiber layer thickness; TMV = total
macular volume; ONHV = optic nerve head volume; ONHH = optic nerve head
height; SD = standard deviation; Min = minimum value; Max = maximum
value; GEE = generalized estimating equation models analyses accounting for
inter–eye/intra-patient dependencies; B = regression coefficient; SE =
coefficient standard error; p = p value.
doi:10.1371/journal.pone.0036965.t002
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duration and treatment of our patient cohort could have a
downsizing effect on the measured RNFLT. This is supported by a
follow-up study to the above-mentioned trial that identified a
significant decrease in disc swelling as detected by OCT after three
months of disease duration and treatment [25]. Second, peripap-
illary RNFLT is limited in describing optic disc swelling because it
measures the boundaries of the process only indirectly. In contrast,
our study directly quantified papilledema by a novel analysis
algorithm, which enables the investigator to gain more detailed
information about ONH swelling itself. Although our patients still
C D
A B
*** ***
Figure 2. ONH volume and height differences between IIH patients and controls. A) 3D spectral domain OCT ONH measurement from a
matched control ONH B) 3D spectral domain OCT ONH measurement from an IIH patient with a diagnosed papilledema C) Groups differences in
optic nerve head volume (ONHV) between IIH patients (black bar) and controls (white bar). D) Group difference in ONHV between medically
untreated (gray bar) and treated (vertical lines bar) IIH patients. Error bars represent 1x standard deviation in figures c and d. = p ,0.001.
doi:10.1371/journal.pone.0036965.g002
Table 3. Subgroup analysis of OCT measurements in medically treated and untreated IIH patients.
untreated (n =11 eyes) treated (n=26 eyes) GEE
Mean±SD Min–Max Mean ± SD Min–Max
RNFLT (mm) 112.5619.2 90.3–155.5 93.4614.5 58.4–120.5 p=0.030
B= 17.6; SE = 8.1
TMV (mm3) 8.4160.34 7.8–8.9 8.5160.43 7.72–9.01 p = 0.720
ONHV (mm3) 3.5761.13 1.626.0 1.7660.86 0.41–4.22 p,0.001
B= 1.8; SE = 0.4
ONHH (mm) 0.4660.09 0.3720.64 0.4060.05 0.3420.57 p = 0.055
Abbreviations: RNFLT = retinal nerve fiber layer thickness; TMV = total macular volume; ONHV = optic nerve head volume; ONHH = optic nerve head height; SD =
standard deviation; Min = minimum value; Max = maximum value; GEE = generalized estimating equation models analyses accounting for inter-eye/intra-patient
dependencies; B = regression coefficient; SE = coefficient standard error; p = p value.
doi:10.1371/journal.pone.0036965.t003
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had detectable changes in OCT using this ONH analysis, these
changes were just not prominent enough to show in RNFLT.
Third, some of the patients in this study even showed pronounced
RNFL loss, leading i.e. to an AUC of ,0.5. We presume, that this
RNFL thinning could be a consequence of the high ICP for years,
causing neuroaxonal damage and loss [33,34].
Unfortunately it was not possible to perform ICP and OCT
measurements at the same time in this pilot trial, which is also the
greatest limitation of our study. The significant association of ICP
with ONHV when weighting for ICP measurement time distance
from OCT points towards a possible direct correlation between
ICP and ONH shape. However, these results should be
interpreted with care: Since scaling of the weighting variable is
unknown and was thus selected arbitrarily, the used statistical
model might not be applicable. Confirmation of these results is
therefore highly warranted in controlled trials merging time points
of ICP and OCT measurements.
Our study points out the urgent need for specialized analysis
protocols for neurologic diseases using OCT. Although OCT’s
informative value is limited to the retina, its value in combination
with powerful and specialized software for applications in
neurology can be greatly improved. Overall, the detection of the
optic disc volume and height makes SDOCT in combination with
the newly developed segmentation algorithm a valuable tool for
evaluating papilledema in IIH patients. The custom segmentation
method should be further developed for and applied in follow-up
trials to determine reliability, precision and ultimately diagnostic
value with sensitivity and specificity. Further statistical optimiza-
tion could e.g. be achieved by combining information from both
eyes into differential diagnosis models.
In summary, our findings suggest ONH volume scans as a
diagnostic and progression parameter in IIH with higher
sensitivity to ICP changes than RNFLT. OCT is a fast and
inexpensive method. A typical examination does not exceed
10 minutes per eye. Thus, OCT could promise a fast and easy
alternative to repeat lumbar punctures, exercised in Europe to
follow IIH patients, and could therefore ease monitoring of disease
progression and treatment response. Furthermore, the methods for
quantifying ONH swelling should potentially be applicable in
other disorders with elevated intracranial pressure that lead to
papilledema.
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